TrialBreast cancer research : BCR2012

Results of a phase II open-label, non-randomized trial of cisplatin chemotherapy in patients with BRCA1-positive metastatic breast cancer.

Tomasz Byrski et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.